Published in J Virol on January 01, 1980
A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol (1988) 13.93
Foot-and-mouth disease. Clin Microbiol Rev (2004) 4.34
Characterization of foot-and-mouth disease virus gene products with antisera against bacterially synthesized fusion proteins. J Virol (1986) 3.89
Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res (1984) 3.81
Identification of the initiation site of poliovirus polyprotein synthesis. J Virol (1982) 3.62
Functional analysis of the internal translation initiation site of foot-and-mouth disease virus. J Virol (1990) 3.08
The complete nucleotide sequence of the RNA coding for the primary translation product of foot and mouth disease virus. Nucleic Acids Res (1984) 3.00
Encephalomyocarditis virus 3C protease: efficient cell-free expression from clones which link viral 5' noncoding sequences to the P3 region. J Virol (1986) 2.72
Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12. J Virol (1985) 2.65
Structure of the FMDV translation initiation site and of the structural proteins. Nucleic Acids Res (1983) 2.58
All foot and mouth disease virus serotypes initiate protein synthesis at two separate AUGs. Nucleic Acids Res (1987) 2.22
Effects of cDNA hybridization on translation of encephalomyocarditis virus RNA. J Virol (1987) 2.02
Potential secondary and tertiary structure in the genomic RNA of foot and mouth disease virus. Nucleic Acids Res (1987) 1.62
Foot-and-mouth disease virus Lb proteinase can stimulate rhinovirus and enterovirus IRES-driven translation and cleave several proteins of cellular and viral origin. J Virol (1995) 1.48
Binding of ribosomes to the 5' leader sequence (N = 258) of RNA 3 from alfalfa mosaic virus. Nucleic Acids Res (1981) 1.47
Biochemical map of polypeptides specified by foot-and-mouth disease virus. J Virol (1984) 1.46
Multiple proteases in foot-and-mouth disease virus replication. J Virol (1984) 1.18
Orientation of the cleavage map of the 200-kilodalton polypeptide encoded by the bottom-component RNA of cowpea mosaic virus. J Virol (1983) 1.17
Genomic RNA of mengovirus V. Recognition of common features by ribosomes and eucaryotic initiation factor 2. J Virol (1982) 1.00
Removal of the genome-linked protein of foot-and-mouth disease virus by rabbit reticulocyte lysate. J Virol (1981) 0.97
Comparison of the nucleotide sequence at the 5' end of RNAs from nine aphthoviruses, including representatives of the Seven serotypes. J Virol (1980) 0.97
Binding of wheat germ ribosomes to fragmented viral mRNA. J Virol (1980) 0.96
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem (1974) 113.22
An efficient mRNA-dependent translation system from reticulocyte lysates. Eur J Biochem (1976) 46.42
Further evidence on the formation of poliovirus proteins. J Mol Biol (1970) 9.29
A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A (1977) 7.92
5'-terminal structure of poliovirus polyribosomal RNA is pUp. Proc Natl Acad Sci U S A (1976) 6.78
Translation of encephalomyocarditis virus RNA in vitro yields an active proteolytic processing enzyme. Eur J Biochem (1978) 4.16
Cell-free synthesis and processing of the proteins of poliovirus. Proc Natl Acad Sci U S A (1978) 3.39
Complete translation of encephalomyocarditis virus RNA and faithful cleavage of virus-specific proteins in a cell-free system from Krebs-2 cells. FEBS Lett (1978) 2.75
Protein covalently linked to foot-and-mouth disease virus RNA. Nature (1977) 2.35
A re-appraisal of the biochemical map of foot-and-mouth disease virus RNA. J Gen Virol (1978) 2.06
Poly(C) in animal viral RNAs. Nature (1974) 1.95
Sequence and location of the poly C tract in aphtho- and cardiovirus RNA. Nucleic Acids Res (1979) 1.95
More precise location of the polycytidylic acid tract in foot and mouth disease virus RNA. J Virol (1978) 1.69
The location of the ploy(C) tract in the RNA of foot-and-mouth disease virus. J Gen Virol (1976) 1.52
Biochemical analysis of a virulent and an avirulent strain of foot-and-mouth disease virus. J Gen Virol (1977) 1.52
Purification and identification of the RNA-dependent RNA polymerase of foot-and-mouth disease virus. J Gen Virol (1979) 1.50
Translation of fragmented viral RNA in vitro: initiation at multiple sites. FEBS Lett (1979) 1.46
Evidence of ambiguous processing and selective degradation in the noncapsid proteins of rhinovirus 1A. J Virol (1976) 1.43
Tryptic peptide analysis of the structural proteins of vesicular stomatitis virus. J Gen Virol (1978) 1.24
Biochemical mapping of the foot-and-mouth disease virus genome. J Gen Virol (1977) 1.21
Cell-free translation of foot-and-mouth disease virus RNA into identifiable non-capsid and capsid proteins. J Gen Virol (1976) 1.07
Foot-and-mouth disease virus RNA. Presence of 3'-terminal polyriboadenylic acid and absence of amino acid binding ability. Virology (1976) 1.04
Ribonuclease activities associated with purified foot and mouth disease virus. Arch Virol (1978) 0.99
The synthesis of polyadenylated messenger RNA in herpes simplex type I virus infected BHK cells. J Gen Virol (1975) 0.96
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 18.17
The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature (1989) 5.87
Classification of rhabdovirus proteins: a proposal. J Virol (1972) 5.54
Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature (1982) 5.50
Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature (1987) 5.26
O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A (1978) 4.68
Unique features of internal initiation of hepatitis C virus RNA translation. EMBO J (1995) 4.44
Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature (1985) 3.97
The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J Gen Virol (1989) 3.53
The proteins of biologically active sub-units of vesicular stomatitis virus. J Gen Virol (1970) 3.44
Propranolol as ocular hypotensive agent. Br J Ophthalmol (1967) 3.42
Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J (1986) 3.31
Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2) Am J Med Genet (1996) 3.17
The complete nucleotide sequence of the RNA coding for the primary translation product of foot and mouth disease virus. Nucleic Acids Res (1984) 3.00
An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology (1999) 3.00
Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug. Br J Clin Pharmacol (1976) 2.99
A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet (1999) 2.88
Dissection of vesicular stomatitis virus into the infective ribonucleoprotein and immunizing components. J Gen Virol (1970) 2.85
Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc Natl Acad Sci U S A (1984) 2.82
A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature (1988) 2.70
Serological relationships between different strains of vesicular stomatis virus. J Gen Virol (1972) 2.68
The complete amino acid sequence of human complement factor H. Biochem J (1988) 2.63
Kinetic tuning of myosin via a flexible loop adjacent to the nucleotide binding pocket. J Biol Chem (1998) 2.62
Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode. Virology (1984) 2.60
The ribonucleic acids of the infective and interfering components of vesicular stomatitis virus. J Gen Virol (1967) 2.57
Chemical basis of antigenic variation in foot-and-mouth disease virus. Nature (1984) 2.52
Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J Virol (1993) 2.50
Internal initiation of translation of hepatitis C virus RNA: the ribosome entry site is at the authentic initiation codon. RNA (1996) 2.45
3'-Terminal nucleotide sequences in the genome RNA of picornaviruses. Nature (1978) 2.40
Protein covalently linked to foot-and-mouth disease virus RNA. Nature (1977) 2.35
All foot and mouth disease virus serotypes initiate protein synthesis at two separate AUGs. Nucleic Acids Res (1987) 2.22
Characterisation of a rotavirus.20b. Nature (1975) 2.21
Synthesis of calf prochymosin (prorennin) in Escherichia coli. Proc Natl Acad Sci U S A (1983) 2.13
A physico-chemical sub-grouping of the mammalian picornaviruses. J Gen Virol (1973) 2.08
A re-appraisal of the biochemical map of foot-and-mouth disease virus RNA. J Gen Virol (1978) 2.06
The replication of picornaviruses. J Gen Virol (1979) 2.03
Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature (1987) 2.00
Poly(C) in animal viral RNAs. Nature (1974) 1.95
Sequence and location of the poly C tract in aphtho- and cardiovirus RNA. Nucleic Acids Res (1979) 1.95
The cloning and nucleotide sequence of cDNA for an amplified glutamine synthetase gene from the Chinese hamster. Nucleic Acids Res (1986) 1.95
Model for vesicular stomatitis virus. J Virol (1972) 1.92
Infective virus substructure from vesicular stomatitis virus. J Virol (1967) 1.89
The antigens of vesicular stomatitis virus. I. Separation and immunogenicity of three complement-fixing components. J Immunol (1966) 1.89
Analysis and gene assignment of mRNAs of a paramyxovirus, simian virus 5. Virology (1984) 1.88
Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature (1990) 1.86
Surface structure of vesicular stomatitis virus. J Gen Virol (1969) 1.82
The nucleotide sequence of cDNA coding for the structural proteins of foot-and-mouth disease virus. Gene (1982) 1.82
Further physicochemical characterization of Nodamura virus. Evidence that the divided genome occurs in a single component. J Gen Virol (1978) 1.78
Molecular cloning and nucleotide sequence of cDNA coding for calf preprochymosin. Nucleic Acids Res (1982) 1.75
A foot and mouth disease syndrome in pigs caused by an enterovirus. Nature (1968) 1.74
Molecular cloning of foot and mouth disease virus genome and nucleotide sequences in the structural protein genes. Nature (1981) 1.73
Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology (1998) 1.73
Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology (1993) 1.72
Diazoxide in treatment of primary pulmonary hypertension. Br Heart J (1978) 1.71
More precise location of the polycytidylic acid tract in foot and mouth disease virus RNA. J Virol (1978) 1.69
Presence of a covalently linked protein on calicivirus RNA. J Gen Virol (1978) 1.66
Comparison of the amino acid sequence of the major immunogen from three serotypes of foot and mouth disease virus. Nucleic Acids Res (1982) 1.66
Antigenic differences between isolates of swine vesicular disease virus and their relationship to Coxsackie B5 virus. Nature (1973) 1.63
Testing drug response in the presence of genetic information: sampling issues for clinical trials. Pharmacogenetics (2000) 1.62
Potential secondary and tertiary structure in the genomic RNA of foot and mouth disease virus. Nucleic Acids Res (1987) 1.62
Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA. Vaccine (1999) 1.61
Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature (1987) 1.57
Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism. J Med Genet (2003) 1.53
The location of the ploy(C) tract in the RNA of foot-and-mouth disease virus. J Gen Virol (1976) 1.52
Biochemical analysis of a virulent and an avirulent strain of foot-and-mouth disease virus. J Gen Virol (1977) 1.52
Heterogeneity of the genome-linked protein of foot-and-mouth disease virus. J Virol (1980) 1.50
Purification and identification of the RNA-dependent RNA polymerase of foot-and-mouth disease virus. J Gen Virol (1979) 1.50
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother (2000) 1.50
Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. Hepatology (1995) 1.50
Beta-sympathetic blockade in hyperthyroidism. Lancet (1966) 1.49
Sequences of vesicular stomatitis virus RNA in the region coding for leader RNA, N protein mRNA, and their junction. Proc Natl Acad Sci U S A (1979) 1.48
Transient expression of cellular polypyrimidine-tract binding protein stimulates cap-independent translation directed by both picornaviral and flaviviral internal ribosome entry sites In vivo. Mol Cell Biol (2000) 1.47